Yes definitely will be a factor in it for sure...this is why some protocols are IBW - Ideal Body Weight, they take the weight of the person into account.
"The amount of fat tissue in a person’s body increases the distribution space and thereby lowers the serum concentrations of fat soluble medications, which can in turn affect the effectiveness of the drug".
Ref:
https://stop.publichealth.gwu.edu/LFD-apr23
The PR, page-7
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $261.4K | 990.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 9445 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |